56. Behcet disease
68 clinical trials,   87 drugs   (DrugBank: 31 drugs),   36 drug target genes,   113 drug target pathways

Searched query = "Behcet disease", "Behçet disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00664599
(ClinicalTrials.gov)
April 200620/4/2008Rituximab for the Treatment of Severe Ocular Manifestations of Behcet's DiseaseEffect of Rituximab in the Treatment of Resistant Ocular Inflammatory Lesions of Behcet's Disease (Pilot Study)Behcet's SyndromeDrug: Rituximab;Drug: Cytotoxic CombinationTehran University of Medical SciencesHoffmann-La RocheCompleted16 YearsN/ABoth20Phase 2Iran, Islamic Republic of